Thursday, 11 June 2020

Japan's PeptiDream to work with Merck in developing COVID-19 therapies

Japanese drug-discovery company PeptiDream Inc said on Friday it would collaborate with Merck & Co in developing COVID-19 therapies.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)